RECRUITING

Universal Genetic Testing for Cancer Risk Reduction

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.

Official Title

Universal Genetic Testing for Cancer Risk Reduction

Quick Facts

Study Start:2025-03-04
Study Completion:2027-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06926816

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 39 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Female patients between ages of 25-39 years at the time of visit
  2. 2. Receive gynecologic care at an affiliated NYU Langone Health (NYULH) site listed in this protocol.
  1. 1. Personal history of ovarian, fallopian tube, primary peritoneal, or uterine cancers
  2. 2. Previously undergone germline testing for ovarian cancer risk variants (prior commercial saliva-based kits, such as 23andMe, are acceptable)
  3. 3. History of bilateral salpingo-oophorectomy
  4. 4. Visit related to pregnancy or immediately postpartum (within 2 weeks)

Contacts and Locations

Study Contact

Bhavan Pothuri, MD, MS
CONTACT
212-731-6455
Bhanava.pothuri@nyulangone.org
Sarah Lee
CONTACT
646-501-7876
Sarah.lee@nyulangone.org

Principal Investigator

Bhavana Pothuri, MD, MS
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Bhavana Pothuri, MD, MS, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-04
Study Completion Date2027-12-31

Study Record Updates

Study Start Date2025-03-04
Study Completion Date2027-12-31

Terms related to this study

Keywords Provided by Researchers

  • Cancer

Additional Relevant MeSH Terms

  • Genetic Testing